First Albany Starts Altair Nanotechnologies (ALTI) at Neutral
- LinkedIn (LNKD) Tops Q2 EPS by 25c
- Market Wrap: Revised Q2 GDP Misses Mark; SoulCycle Files for IPO; LinkedIn Limps on Premium Sub Slowdown
- Coca-Cola Enterprises (CCE) in Talks to Combine with Other Bottlers - WSJ
- After-Hours Stock Movers 07/30: (YRCW) (COLM) (ZLTQ) Higher; (OCLS) (EA) (LNKD) Lower (more...)
- Amgen (AMGN) Tops Q2 EPS by 14c, Raises FY Guidance
First Albany initiates coverage on Altair Nanotechnologies (Nasdaq: ALTI) with a Neutral rating.
You May Also Be Interested In
- UPDATE: JPMorgan Cuts Garmin (GRMN) to Underweight on Decelerating Growth in Fitness
- Needham & Company Cuts Price Target on Cavium (CAVM) to $83 Following 2Q15
- Facebook (FB) PT Raised to $107 at Mizuho Securities
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!